uniQure N.V. - Ordinary Shares (QURE) Covered Calls

uniQure NV is engaged in the field of gene therapy and has developed a gene therapy product to receive regulatory approval in the European Union.

You can sell covered calls on uniQure N.V. - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for QURE (prices last updated Tue 4:16 PM ET):

uniQure N.V. - Ordinary Shares (QURE) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
21.75	+1.25	21.53	22.26	1.9M	-	1.3

Covered Calls For uniQure N.V. - Ordinary Shares (QURE)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Feb 20	22	0.90	21.36	3.0%	274%
Mar 20	22	6.40	15.86	38.7%	441%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

uniQure NV engages in the discovery, development, and commercialization of gene therapies. Its core gene therapies include AMT-060 for the treatment of hemophilia B; preclinical S100A1 therapeutic for the treatment of congestive heart failure; and Glybera a gene therapy that is designed to restore the LPL enzyme activity required to enable the processing, or clearance, of fat-carrying chylomicron particles formed in the intestine after a fat-containing meal. uniQure was founded on January 9, 2012 and is headquartered in Amsterdam, Netherlands.

Top 10 Open Interest For Feb 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	SPY covered calls	1.	PANW covered calls
2.	SLV covered calls	7.	QQQ covered calls	2.	SEDG covered calls
3.	GLD covered calls	8.	TLT covered calls	3.	AXTI covered calls
4.	KWEB covered calls	9.	TSLA covered calls	4.	AMPL covered calls
5.	IBIT covered calls	10.	INTC covered calls	5.	FIG covered calls

Want more examples? QUIK Covered Calls | QUS Covered Calls